2 dirt-cheap dividend investment trusts that could make you a millionaire

These two investment trusts could offer stunning long-term performance.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Finding companies which offer a mix of high dividend yields and low valuations is never easy. That task has been made more difficult in recent months, however, by the rise in the rate of inflation. It now stands at 2.9%, and this means that investors are becoming more positive on the investment potential of higher-yielding shares as they seek to generate an income return which is higher than inflation.

Alongside this, the FTSE 100 continues to trade close to an all-time high. This means there may be fewer dirt-cheap stocks around. However, while that may be the case, here are two companies which appear to offer a potent mix of high yields and low valuations.

Solid performance

Reporting on Friday was real estate investment trust (REIT) Impact Healthcare (LSE: IHR). The company owns a diversified portfolio of healthcare real estate opportunities, particularly residential care homes. It has acquired 57 care homes since its IPO in March 2017, with an average net initial yield of 7.6%.

Encouragingly, the portfolio has been 100% let and is income-producing. This has meant that the company’s dividend was fully covered against its adjusted earnings in its most recent reporting period. With it on track to pay out 4.5p in the three quarters to 31 December, it has an annualised dividend yield of around 5.8%. This is twice the current rate of inflation and means that the trust may become more popular among income-hungry investors.

With a net asset value per share of 100p, Impact Healthcare appears to offer excellent value for money. It has a price-to-book (P/B) ratio of just over 1, which indicates that it may offer capital growth potential in the long run. With it being a relatively stable and resilient business model, it could also provide defensive characteristics at a time when the outlook for the UK economy is highly uncertain.

Growth potential

Also offering a mix of a high yield and low valuation is developer and operator of student property Unite Group (LSE: UTG). It has a strong growth opportunity due to the pressure on housing supply in the UK. While a large number of students are international postgraduate students, they are unlikely to be affected by Brexit as they often stay for one year or less. Therefore, demand for student accommodation could remain buoyant and lead to higher rents across the sector.

With a dividend yield of 3.3%, Unite Group offers an inflation-beating income return. Dividends are likely to rise over the medium term, since the company is forecast to grow its earnings by 7% in the current year and by a further 15% next year. Since it has a dividend coverage ratio of 1.3, shareholder payouts could rise by at least as much as profit growth. And with the company trading on a price-to-earnings growth (PEG) ratio of 1.2, it could offer significant capital growth potential.

Peter Stephens does not own shares in any companies mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Person holding magnifying glass over important document, reading the small print
Investing Articles

Aviva’s share price is down 13% to under £7, despite outstanding 2025 results! Time for me to buy more?

I think Aviva’s share price reflects an outdated view of the business, and that gap between perception and reality is…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

Shell’s £33+ share price is near an all-time high, so why am I going to buy more as soon as possible?

Shell's strong cash generation and improving growth drivers contrast with a share price well below my valuation, suggesting major long‑term…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

An 8.4% forecast yield but down 16%! Time for me to buy more of this FTSE 100 passive income star?

This FTSE 100 passive‑income machine is delivering rising payouts and strong forecasts, and its share price suggests the market hasn’t…

Read more »

CEO Mark Zuckerberg at F8 2019 event
Investing Articles

£10,000 invested in Meta Platforms Stock 5 years ago is now worth…

Meta Platforms has been throwing good money after bad at Reality Labs since 2021, but the stock has more than…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

£7,500 invested in Diageo shares 5 weeks ago is now worth…

Our writer wonders if Diageo shares are worth a look at a 14-year low, or whether this FTSE 100 spirits…

Read more »

National Grid engineers at a substation
Investing Articles

Is Warren Buffett’s firm about to buy this FTSE 100 company?

There’s always speculation about what Warren Buffett’s company might be doing. But one UK idea has a bit more to…

Read more »

Female student sitting at the steps and using laptop
Growth Shares

Down 17% in a month, this household FTSE 250 stock looks cheap

Jon Smith acknowledges the recent market sell-off but points out a FTSE 250 stock that he believes offers a long-term…

Read more »

Hydrogen testing at DLR Cologne
Investing Articles

Rolls-Royce’s share price has plunged 16% from its highs! Time to buy?

Rolls-Royce's share price has tumbled in less than three weeks. Royston Wild asks: is the FTSE 100 engineering stock now…

Read more »